Exact Mass: 458.2672
Exact Mass Matches: 458.2672
Found 297 metabolites which its exact mass value is equals to given mass value 458.2672
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Prednisolone tebutate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
Lucidenic acid A
Lucidenic acid A is found in mushrooms. Lucidenic acid A is a metabolite of Ganoderma lucidum (reishi). Lucideric acid A is a natural compound isolated from Ganoderma lucidum, inhibits PMA-induced MMP-9 activity, with anti-invasive effect on hepatoma cells[1]. Lucideric acid A is a natural compound isolated from Ganoderma lucidum, inhibits PMA-induced MMP-9 activity, with anti-invasive effect on hepatoma cells[1].
Motolimod
C308 - Immunotherapeutic Agent > C2139 - Immunostimulant > C177174 - Toll-like Receptor Agonist
LucidenicacidA
Lucidenic acid A is a triterpenoid. lucidenic acid A is a natural product found in Ganoderma lucidum with data available. D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids Lucideric acid A is a natural compound isolated from Ganoderma lucidum, inhibits PMA-induced MMP-9 activity, with anti-invasive effect on hepatoma cells[1]. Lucideric acid A is a natural compound isolated from Ganoderma lucidum, inhibits PMA-induced MMP-9 activity, with anti-invasive effect on hepatoma cells[1].
DECAETHYLENE GLYCOL
CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 9 INTERNAL_ID 9; CONFIDENCE Reference Standard (Level 1)
methyl (2R)-2-[(3R,4R)-3-[(1E,3E,5E,7E)-8-[(2S,3R,6S)-3,6-dihydro-3-hydroxy-3,5,6-trimethyl-2H-pyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-3,4-dimethyl-5-oxotetrahydrofuran-2--l]propanoate|wortmannilactone G
Ganolactone B
ent-3beta-acetoxy-14beta-tigloyloxybeyer-15-en-19-oic acid
{(Z)-3-(chloromethylene)-2,3-dihydrobenzo[b]oxepin-7-yl}methyl palmitoleate
(7R,8S)-7-hydroxyl-3-[(1R,2R,4S)-4-hydroxy-2-methyl-6-oxocyclohexyl]-7-methyl-8-[(3S)-3-methyl-2-oxononyl]-7,8-dihydro-6H-isochromen-6-one|cohaerin I
20(21)-dehydrolucidenic acid N|3beta,7beta-dihydroxy-11,15-dioxo-25,26,27-trinorlanosta-8,20(21)-dien-24-oic acid
17-acetoxy-3alpha-angeloyloxy-15,16-epoxycleistanth-12-en-11-one
Lucidenic acid A
Metabolite of Ganoderma lucidum (reishi). Lucidenic acid A is found in mushrooms. Lucideric acid A is a natural compound isolated from Ganoderma lucidum, inhibits PMA-induced MMP-9 activity, with anti-invasive effect on hepatoma cells[1]. Lucideric acid A is a natural compound isolated from Ganoderma lucidum, inhibits PMA-induced MMP-9 activity, with anti-invasive effect on hepatoma cells[1].
C27H38O6_(5xi,8alpha,9xi,10alpha)-14-Acetoxy-15-{[(2Z)-2-methyl-2-butenoyl]oxy}kaur-16-en-18-oic acid
Ala Gly Arg Arg
Ala Asn Arg Val
Ala Asn Val Arg
Ala Arg Gly Arg
Ala Arg Asn Val
Ala Arg Arg Gly
Ala Arg Val Asn
Ala Val Asn Arg
Ala Val Arg Asn
Asp Ile Ile Val
Asp Ile Leu Val
Asp Ile Val Ile
Asp Ile Val Leu
Asp Leu Ile Val
Asp Leu Leu Val
Asp Leu Val Ile
Asp Leu Val Leu
Asp Val Ile Ile
Asp Val Ile Leu
Asp Val Leu Ile
Asp Val Leu Leu
Glu Ile Val Val
Glu Leu Val Val
Glu Val Ile Val
Glu Val Leu Val
Glu Val Val Ile
Glu Val Val Leu
Gly Ala Arg Arg
Gly Ile Asn Arg
Gly Ile Arg Asn
Gly Leu Asn Arg
Gly Leu Arg Asn
Gly Asn Ile Arg
Gly Asn Leu Arg
Gly Asn Arg Ile
Gly Asn Arg Leu
Gly Gln Arg Val
Gly Gln Val Arg
Gly Arg Ala Arg
Gly Arg Ile Asn
Gly Arg Leu Asn
Gly Arg Asn Ile
Gly Arg Asn Leu
Gly Arg Gln Val
Gly Arg Arg Ala
Gly Arg Val Gln
Gly Val Gln Arg
Gly Val Arg Gln
Ile Asp Ile Val
Ile Asp Leu Val
Ile Asp Val Ile
Ile Asp Val Leu
Ile Glu Val Val
Ile Gly Asn Arg
Ile Gly Arg Asn
Ile Ile Asp Val
Ile Ile Val Asp
Ile Leu Asp Val
Ile Leu Val Asp
Ile Asn Gly Arg
Ile Asn Arg Gly
Ile Arg Gly Asn
Ile Arg Asn Gly
Ile Val Asp Ile
Ile Val Asp Leu
Ile Val Glu Val
Ile Val Ile Asp
Ile Val Leu Asp
Ile Val Val Glu
Leu Asp Ile Val
Leu Asp Leu Val
Leu Asp Val Ile
Leu Asp Val Leu
Leu Glu Val Val
Leu Gly Asn Arg
Leu Gly Arg Asn
Leu Ile Asp Val
Leu Ile Val Asp
Leu Leu Asp Val
Leu Leu Val Asp
Leu Asn Gly Arg
Leu Asn Arg Gly
Leu Arg Gly Asn
Leu Arg Asn Gly
Leu Val Asp Ile
Leu Val Asp Leu
Leu Val Glu Val
Leu Val Ile Asp
Leu Val Leu Asp
Leu Val Val Glu
Asn Ala Arg Val
Asn Ala Val Arg
Asn Gly Ile Arg
Asn Gly Leu Arg
Asn Gly Arg Ile
Asn Gly Arg Leu
Asn Ile Gly Arg
Asn Ile Arg Gly
Asn Leu Gly Arg
Asn Leu Arg Gly
Asn Arg Ala Val
Asn Arg Gly Ile
Asn Arg Gly Leu
Asn Arg Ile Gly
Asn Arg Leu Gly
Asn Arg Val Ala
Asn Val Ala Arg
Asn Val Arg Ala
Gln Gly Arg Val
Gln Gly Val Arg
Gln Arg Gly Val
Gln Arg Val Gly
Gln Val Gly Arg
Gln Val Arg Gly
Arg Ala Gly Arg
Arg Ala Asn Val
Arg Ala Arg Gly
Arg Ala Val Asn
Arg Gly Ala Arg
Arg Gly Ile Asn
Arg Gly Leu Asn
Arg Gly Asn Ile
Arg Gly Asn Leu
Arg Gly Gln Val
Arg Gly Arg Ala
Arg Gly Val Gln
Arg Ile Gly Asn
Arg Ile Asn Gly
Arg Leu Gly Asn
Arg Leu Asn Gly
Arg Asn Ala Val
Arg Asn Gly Ile
Arg Asn Gly Leu
Arg Asn Ile Gly
Arg Asn Leu Gly
Arg Asn Val Ala
Arg Gln Gly Val
Arg Gln Val Gly
Arg Arg Ala Gly
Arg Arg Gly Ala
Arg Val Ala Asn
Arg Val Gly Gln
Arg Val Asn Ala
Arg Val Gln Gly
Val Ala Asn Arg
Val Ala Arg Asn
Val Asp Ile Ile
Val Asp Ile Leu
Val Asp Leu Ile
Val Asp Leu Leu
Val Glu Ile Val
Val Glu Leu Val
Val Glu Val Ile
Val Glu Val Leu
Val Gly Gln Arg
Val Gly Arg Gln
Val Ile Asp Ile
Val Ile Asp Leu
Val Ile Glu Val
Val Ile Ile Asp
Val Ile Leu Asp
Val Ile Val Glu
Val Leu Asp Ile
Val Leu Asp Leu
Val Leu Glu Val
Val Leu Ile Asp
Val Leu Leu Asp
Val Leu Val Glu
Val Asn Ala Arg
Val Asn Arg Ala
Val Gln Gly Arg
Val Gln Arg Gly
Val Arg Ala Asn
Val Arg Gly Gln
Val Arg Asn Ala
Val Arg Gln Gly
Val Val Glu Ile
Val Val Glu Leu
Val Val Ile Glu
Val Val Leu Glu
N-(4-benzenesulfonamide)arachidonoyl amide
butyl prop-2-enoate,methyl 2-methylprop-2-enoate,prop-2-enyl 2-methylprop-2-enoate,styrene
Motolimod
C308 - Immunotherapeutic Agent > C2139 - Immunostimulant > C177174 - Toll-like Receptor Agonist
[(1S,2R,3R,4S,5R)-5-azaniumyl-2-[(2R,3R,4R,5S,6R)-3-azaniumyl-6-(azaniumylmethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-[(2S,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4-hydroxycyclohexyl]azanium
1-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-phenylurea
1-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-phenylurea
1-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-phenylurea
1-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-phenylurea
1-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-phenylurea
1-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-phenylurea
1-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-phenylurea
1-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-phenylurea
1-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methyl-3-phenylurea
(1S,15S,18S,19S,20S)-N-[2-(4-aminophenyl)ethyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide
(1S,5R,9S,10R,13R)-16-acetyloxy-5,9-dimethyl-15-[(Z)-2-methylbut-2-enoyl]oxy-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylic acid
Ribostamycin(4+)
An organic cation obtained by protonation of the four amino groups of ribostamycin; major species at pH 7.3.